Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126568502 | 12656850 | 2 | F | 20151211 | 20160905 | 20160816 | 20160915 | EXP | JP-009507513-1608JPN007468 | MERCK | 79.00 | YR | F | Y | 46.50000 | KG | 20160915 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126568502 | 12656850 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | 600 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 50400 | MG | U | 20903 | 600 | MG | CAPSULE | QD | |||
| 126568502 | 12656850 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 34000 | MG | 0 | 400 | MG | QD | |||||
| 126568502 | 12656850 | 3 | C | DOGMATYL | SULPIRIDE | 1 | Oral | 150 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 150 | MG | QD | |||||||
| 126568502 | 12656850 | 4 | C | URSO | URSODIOL | 1 | Oral | 600 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 600 | MG | QD | |||||||
| 126568502 | 12656850 | 5 | C | RIZE | CLOTIAZEPAM | 1 | Oral | 150 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 150 | MG | QD | |||||||
| 126568502 | 12656850 | 6 | C | HALCION | TRIAZOLAM | 1 | Oral | 0.25 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | .25 | MG | QD | |||||||
| 126568502 | 12656850 | 7 | C | SILECE | FLUNITRAZEPAM | 1 | Oral | 1 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 1 | MG | QD | |||||||
| 126568502 | 12656850 | 8 | C | PAXIL CR | PAROXETINE HYDROCHLORIDE | 1 | Oral | 12.5 MG, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 12.5 | MG | TABLET | QD | ||||||
| 126568502 | 12656850 | 9 | C | HOCHU-EKKI-TO | UNSPECIFIED INGREDIENT | 1 | Oral | 7.5 G, DAILY (DIVIDED DOSE, FREQUENCY UNKNOWN) | 0 | 7.5 | G | QD | |||||||
| 126568502 | 12656850 | 10 | C | ALLELOCK | OLOPATADINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD (DIVIDED DOSE FREQUENCY UNKNOWN) | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126568502 | 12656850 | 1 | Chronic hepatitis C |
| 126568502 | 12656850 | 3 | Depression |
| 126568502 | 12656850 | 4 | Chronic hepatitis C |
| 126568502 | 12656850 | 5 | Anxiety disorder |
| 126568502 | 12656850 | 6 | Insomnia |
| 126568502 | 12656850 | 7 | Insomnia |
| 126568502 | 12656850 | 8 | Depression |
| 126568502 | 12656850 | 9 | Decreased appetite |
| 126568502 | 12656850 | 10 | Rash |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126568502 | 12656850 | OT |
| 126568502 | 12656850 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126568502 | 12656850 | Hepatic cancer | |
| 126568502 | 12656850 | Hepatitis | |
| 126568502 | 12656850 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126568502 | 12656850 | 1 | 20151127 | 20160218 | 0 | |
| 126568502 | 12656850 | 2 | 20151127 | 20160219 | 0 | |
| 126568502 | 12656850 | 3 | 20081220 | 0 | ||
| 126568502 | 12656850 | 4 | 20090314 | 0 | ||
| 126568502 | 12656850 | 5 | 20090916 | 0 | ||
| 126568502 | 12656850 | 6 | 20090328 | 0 | ||
| 126568502 | 12656850 | 7 | 20120608 | 0 | ||
| 126568502 | 12656850 | 8 | 20140609 | 0 | ||
| 126568502 | 12656850 | 9 | 20130710 | 0 | ||
| 126568502 | 12656850 | 10 | 20151211 | 0 |